Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Thymosin Alpha-1 and BAC Water Mix

Thymosin Alpha-1 Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Thymosin Alpha-1 Titration Schedule

ParameterDetails
Dose1.6 mg SC per injection
FrequencyTwice weekly (Mon/Thu)
Cycle6–12 months (label)

The twice-weekly 1.6 mg schedule is exactly the Zadaxin label. The 'daily ×1 week loading' phase has no trial basis — the label starts directly at the target dose. Approved in 35+ countries (HBV/HCV/cancer adjuvant); not FDA-approved. The sepsis Phase 3 (n=1,106) failed its primary endpoint.

Possible vial strengths:

What Is It?

Thymosin Alpha-1

Thymic peptide studied for immune modulation.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Thymosin Alpha-1

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Thymosin Alpha-1 Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Yes, “hymosin alpha 1” is usually a misspelling of thymosin alpha 1. For calculator math, the key details are still the vial amount and the final liquid volume, which determine the concentration.
It shows how concentrated the mixed solution is after liquid is added. The usual output is mg/mL or mcg/mL, not a recommendation for use, timing, or treatment.
The calculator cannot estimate concentration from the name alone. A 5 mg vial, a 10 mg vial, and another labeled strength will all produce different mcg/mL values when mixed with the same liquid volume.
No. A reconstitution calculator can only convert vial strength and liquid volume into concentration. It should not provide dosage, frequency, immune-use protocols, or personal medical guidance.
A calculator result is only useful if the listing clearly states the vial amount, compound identity, and batch documentation. It cannot verify legality, quality, sterility, or whether a product is suitable for human use.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides